Cargando…
Comment on Russell et al. Abatacept for Delay of Type 1 Diabetes Progression in Stage 1 Relatives at Risk: A Randomized, Double-Masked, Controlled Trial. Diabetes Care 2023;46:1005–1013
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Diabetes Association
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10620533/ https://www.ncbi.nlm.nih.gov/pubmed/37890102 http://dx.doi.org/10.2337/dc23-1115 |
| _version_ | 1785130227625623552 |
|---|---|
| author | Pinheiro, Marcelo Maia Pinheiro, Felipe Moura Maia |
| author_facet | Pinheiro, Marcelo Maia Pinheiro, Felipe Moura Maia |
| author_sort | Pinheiro, Marcelo Maia |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10620533 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | American Diabetes Association |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-106205332023-11-03 Comment on Russell et al. Abatacept for Delay of Type 1 Diabetes Progression in Stage 1 Relatives at Risk: A Randomized, Double-Masked, Controlled Trial. Diabetes Care 2023;46:1005–1013 Pinheiro, Marcelo Maia Pinheiro, Felipe Moura Maia Diabetes Care e-Letters – Comments and Responses American Diabetes Association 2023-11 2023-10-27 /pmc/articles/PMC10620533/ /pubmed/37890102 http://dx.doi.org/10.2337/dc23-1115 Text en © 2023 by the American Diabetes Association https://www.diabetesjournals.org/journals/pages/licenseReaders may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at https://www.diabetesjournals.org/journals/pages/license. |
| spellingShingle | e-Letters – Comments and Responses Pinheiro, Marcelo Maia Pinheiro, Felipe Moura Maia Comment on Russell et al. Abatacept for Delay of Type 1 Diabetes Progression in Stage 1 Relatives at Risk: A Randomized, Double-Masked, Controlled Trial. Diabetes Care 2023;46:1005–1013 |
| title | Comment on Russell et al. Abatacept for Delay of Type 1 Diabetes Progression in Stage 1 Relatives at Risk: A Randomized, Double-Masked, Controlled Trial. Diabetes Care 2023;46:1005–1013 |
| title_full | Comment on Russell et al. Abatacept for Delay of Type 1 Diabetes Progression in Stage 1 Relatives at Risk: A Randomized, Double-Masked, Controlled Trial. Diabetes Care 2023;46:1005–1013 |
| title_fullStr | Comment on Russell et al. Abatacept for Delay of Type 1 Diabetes Progression in Stage 1 Relatives at Risk: A Randomized, Double-Masked, Controlled Trial. Diabetes Care 2023;46:1005–1013 |
| title_full_unstemmed | Comment on Russell et al. Abatacept for Delay of Type 1 Diabetes Progression in Stage 1 Relatives at Risk: A Randomized, Double-Masked, Controlled Trial. Diabetes Care 2023;46:1005–1013 |
| title_short | Comment on Russell et al. Abatacept for Delay of Type 1 Diabetes Progression in Stage 1 Relatives at Risk: A Randomized, Double-Masked, Controlled Trial. Diabetes Care 2023;46:1005–1013 |
| title_sort | comment on russell et al. abatacept for delay of type 1 diabetes progression in stage 1 relatives at risk: a randomized, double-masked, controlled trial. diabetes care 2023;46:1005–1013 |
| topic | e-Letters – Comments and Responses |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10620533/ https://www.ncbi.nlm.nih.gov/pubmed/37890102 http://dx.doi.org/10.2337/dc23-1115 |
| work_keys_str_mv | AT pinheiromarcelomaia commentonrusselletalabataceptfordelayoftype1diabetesprogressioninstage1relativesatriskarandomizeddoublemaskedcontrolledtrialdiabetescare20234610051013 AT pinheirofelipemouramaia commentonrusselletalabataceptfordelayoftype1diabetesprogressioninstage1relativesatriskarandomizeddoublemaskedcontrolledtrialdiabetescare20234610051013 |